Cargando…

Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial

BACKGROUND: Understanding which group of patients with type 2 diabetes will have the most glucose lowering response to certain medications (which target different aspects of glucose metabolism) is the first step in precision medicine. AIMS: We hypothesized that people with type 2 diabetes who genera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandon, Rebecca, Jiang, Yannan, Yeu, Rui Qian, Tweedie-Cullen, Ry, Smallman, Kate, Doherty, Glenn, Macaskill-Smith, Kerry A., Doran, Rebekah J., Clark, Penny, Moffitt, Allan, Merry, Troy, Nehren, Norma, King, Frances, Hindmarsh, Jennie Harré, Leask, Megan Patricia, Merriman, Tony R., Orr-Walker, Brandon, Shepherd, Peter R., Paul, Ryan, Murphy, Rinki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869378/ https://www.ncbi.nlm.nih.gov/pubmed/36699039 http://dx.doi.org/10.3389/fendo.2022.1091421

Ejemplares similares

Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol
por: Yeu, Rui Qian, et al.
Publicado: (2020)

Single administration of vildagliptin attenuates postprandial hypertriglyceridemia and endothelial dysfunction in normoglycemic individuals
por: NOGUCHI, KAORU, et al.
Publicado: (2015)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Kim, Jong Ho, et al.
Publicado: (2016)

Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats
por: Eom, Young Sil, et al.
Publicado: (2016)

Liquid Chromatographic Methods for the Determination of Vildagliptin in the Presence of its Synthetic Intermediate and the Simultaneous Determination of Pioglitazone Hydrochloride and Metformin Hydrochloride
por: El-Bagary, Ramzia I., et al.
Publicado: (2011)

Associations Between Sugars Intakes and Urinary Sugars Excretion and Carbon Stable Isotope Ratios in Red Blood Cells as Biomarkers of Sugars Intake in a Predominantly Māori Population
por: Te Morenga, Lisa, et al.
Publicado: (2021)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

Surfing the Vildagliptin Tsunami
por: Balachandran, Karthik
Publicado: (2020)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
por: Flynn, Tanya J, et al.
Publicado: (2015)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study
por: Erande, Suhas, et al.
Publicado: (2023)

Mild acute pancreatitis with vildagliptin use
por: Saraogi, Ravikant, et al.
Publicado: (2012)

Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
por: Wiciński, Michał, et al.
Publicado: (2020)

Hypertriglyceridemia
por: Brahm, Amanda, et al.
Publicado: (2013)

Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption
por: Rasheed, Humaira, et al.
Publicado: (2013)

Effect of a health literacy intervention trial on knowledge about cardiovascular disease medications among Indigenous peoples in Australia, Canada and New Zealand
por: Crengle, Sue, et al.
Publicado: (2018)

Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study
por: Kim, Nam Hoon, et al.
Publicado: (2017)

Rapid resolution of hypertriglyceridemia-induced pancreatitis via plasmapheresis: A unique case report
por: Wang, Victoria, et al.
Publicado: (2023)

A case of vildagliptin-induced interstitial pneumonia
por: Kuse, Naoyuki, et al.
Publicado: (2016)

Physicochemical Properties and Methods of Analysis of Vildagliptin (Review)
por: Polyakova, E. B., et al.
Publicado: (2022)

Cardiovascular disease medication health literacy among Indigenous peoples: design and protocol of an intervention trial in Indigenous primary care services
por: Crengle, Sue, et al.
Publicado: (2014)

Hypertriglyceridemia and atherosclerosis
por: Peng, Jia, et al.
Publicado: (2017)

Genetics of Hypertriglyceridemia
por: Dron, Jacqueline S., et al.
Publicado: (2020)

Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
por: Kudo‐Fujimaki, Kyoko, et al.
Publicado: (2013)

Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers
por: Schnaars, Yvonne, et al.
Publicado: (2022)

The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

Vildagliptin/metformin: Lactic acidosis and hypoglycaemia: case report
Publicado: (2022)

Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study
por: Van Gaal, Luc, et al.
Publicado: (2019)

Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia
por: Cruz-Bautista, Ivette, et al.
Publicado: (2021)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
por: Ved, Paresh, et al.
Publicado: (2012)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
por: Ved, Paresh, et al.
Publicado: (2013)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
por: Mundra, Vishal
Publicado: (2012)

Hypertriglyceridemia in Antiretroviral Therapy
por: Imarhiagbe, Frank Aiwansoba, et al.
Publicado: (2005)

Pioglitazone: Indian perspective
por: Shukla, Rishi, et al.
Publicado: (2011)

Abdominal pain in hypertriglyceridemia
por: Alkimawi, Khalid
Publicado: (2014)

Causes and Consequences of Hypertriglyceridemia
por: Packard, Chris J., et al.
Publicado: (2020)

The Genetic Basis of Hypertriglyceridemia
por: Carrasquilla, Germán D., et al.
Publicado: (2021)

Hypertriglyceridemia-Induced Pancreatitis
por: Mung, Sai Man, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ns3qlq3104effvbl03hqhv41u3